ResMed Inc.
RMD
$208.05
-$0.93-0.45%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.56% | 12.64% | -8.21% | 4.02% | 5.93% |
| Total Depreciation and Amortization | 11.92% | 9.11% | -24.54% | 48.84% | -7.78% |
| Total Amortization of Deferred Charges | 0.55% | -0.11% | 0.90% | 1.31% | -2.22% |
| Total Other Non-Cash Items | 29.82% | 4.86% | -0.60% | -11.60% | 27.98% |
| Change in Net Operating Assets | 135.96% | -663.43% | -57.02% | -55.58% | 215.13% |
| Cash from Operations | 63.10% | -25.71% | -15.12% | -6.89% | 87.50% |
| Capital Expenditure | -17.92% | 33.58% | -40.48% | -47.07% | -0.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 99.62% | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 102.27% | -146.43% | -125.64% | 422.57% | 28.53% |
| Cash from Investing | -13.91% | 3.11% | 60.68% | -320.67% | 13.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -74.87% | 260.23% | -72.79% | 234.21% | -66.43% |
| Repurchase of Common Stock | 10.18% | -29.58% | -49.83% | -33.44% | 17.80% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.40% | 0.19% | -13.09% | 0.15% | -0.01% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.20% | -12.19% | -40.51% | -13.75% | 2.35% |
| Foreign Exchange rate Adjustments | -6.69% | 3,997.18% | -100.20% | 346.73% | 127.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 632.80% | -80.95% | -36.98% | -32.63% | 329.75% |